The global digital health in neurology market size was valued at USD 48.5 billion in 2025 and is projected to grow from USD 59.4 billion in 2026 to USD 246.9 billion in 2033, at a CAGR of 22.6% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 40.0% in 2025. Increasing smartphone penetration, advancing healthcare IT infrastructure, improved internet connectivity, increasing prevalence of chronic diseases, rising healthcare expenditure, growing demand for remote patient monitoring services, and increasing accessibility of virtual care are driving the adoption of digital health technologies in neurology.
The global healthcare sector has encountered numerous challenges during the pandemic. However, these circumstances accelerated the advancement of digital health technologies, especially in disease management, technology development, and frontline care delivery. Many countries have adopted remote monitoring platforms, telemedicine, and telehealth services to facilitate communication between physicians and patients. As a result, the digital health industry experienced significant revenue growth and is expected to continue growing profitably in the coming years, maintaining rapid expansion throughout the forecast period.
Government initiatives promoting global digitalization in healthcare are significantly driving market growth. For example, in January 2024, the European Commission awarded an EU-funded collaborative research infrastructure (RI) grant of approximately USD 41 million to EBRAINS, which will last until 2026. This funding will assist EBRAINS in developing tools and services, such as digital twin approaches, to support communities in brain medicine, neuroscience, and brain-inspired technologies.
The Internet of Things (IoT) has been widely adopted as a digital healthcare platform. With advanced wearable devices, reliable mobile connectivity, and efficient data backup enabled by integrated analytics, IoT has transformed the healthcare industry by facilitating a range of activities. These include efficient tracking of patients, staff, and inventories, managing chronic conditions, optimizing drug prescriptions, and ensuring the availability of essential medical equipment. For instance, in April 2025, Phantom Neuro announced the successful completion of a USD 19 million Series A funding round led by Ottobock to expedite the development and commercialization of its muscle-machine interface technology. This funding will support regulatory activities, product development, and clinical validation of Phantom X, an AI-powered neural interface designed to enable intuitive control of prosthetic limbs and robotic devices.
Smartphones have transformed from simple entertainment and communication devices into essential tools for fitness and health tracking. Health-related applications have made it easier to manage daily activities by offering convenient ways to monitor overall well-being. For example, some companies are developing applications to track sleep patterns. In July 2025, Apollo Neuroscience released Version 4.0 of its Apollo mobile application, which included a redesigned user interface, personalized content recommendations, improved SmartVibes integration, and better connectivity with wearables. These enhancements aim to strengthen the digital therapeutic experience for stress management and neurological well-being.
Similarly, according to the World Health Organization estimates, there are approximately 55 million individuals across the globe suffering from dementia. The consequences are many individuals suffering from the conditions and substantial healthcare costs. According to the World Health Organization's Global Status Report on Neurology published in 2025, neurological conditions now affect more than 40% of the global population, representing over 3 billion people, and remain the leading cause of ill health and disability worldwide. Hence, several companies and research institutes are investing in clinical trials, including the application of digital technologies in neurology.
▪ Canada
▪ Germany
▪ France
▪ Italy
▪ Spain
▪ Sweden
▪ Denmark
▪ Norway
▪ India
▪ Japan
▪ Australia
▪ South Korea
▪ Singapore
▪ Mexico
▪ Argentina
▪ Saudi Arabia
▪ UAE
▪ Kuwait
The global healthcare sector has encountered numerous challenges during the pandemic. However, these circumstances accelerated the advancement of digital health technologies, especially in disease management, technology development, and frontline care delivery. Many countries have adopted remote monitoring platforms, telemedicine, and telehealth services to facilitate communication between physicians and patients. As a result, the digital health industry experienced significant revenue growth and is expected to continue growing profitably in the coming years, maintaining rapid expansion throughout the forecast period.
Government initiatives promoting global digitalization in healthcare are significantly driving market growth. For example, in January 2024, the European Commission awarded an EU-funded collaborative research infrastructure (RI) grant of approximately USD 41 million to EBRAINS, which will last until 2026. This funding will assist EBRAINS in developing tools and services, such as digital twin approaches, to support communities in brain medicine, neuroscience, and brain-inspired technologies.
The Internet of Things (IoT) has been widely adopted as a digital healthcare platform. With advanced wearable devices, reliable mobile connectivity, and efficient data backup enabled by integrated analytics, IoT has transformed the healthcare industry by facilitating a range of activities. These include efficient tracking of patients, staff, and inventories, managing chronic conditions, optimizing drug prescriptions, and ensuring the availability of essential medical equipment. For instance, in April 2025, Phantom Neuro announced the successful completion of a USD 19 million Series A funding round led by Ottobock to expedite the development and commercialization of its muscle-machine interface technology. This funding will support regulatory activities, product development, and clinical validation of Phantom X, an AI-powered neural interface designed to enable intuitive control of prosthetic limbs and robotic devices.
Smartphones have transformed from simple entertainment and communication devices into essential tools for fitness and health tracking. Health-related applications have made it easier to manage daily activities by offering convenient ways to monitor overall well-being. For example, some companies are developing applications to track sleep patterns. In July 2025, Apollo Neuroscience released Version 4.0 of its Apollo mobile application, which included a redesigned user interface, personalized content recommendations, improved SmartVibes integration, and better connectivity with wearables. These enhancements aim to strengthen the digital therapeutic experience for stress management and neurological well-being.
Similarly, according to the World Health Organization estimates, there are approximately 55 million individuals across the globe suffering from dementia. The consequences are many individuals suffering from the conditions and substantial healthcare costs. According to the World Health Organization's Global Status Report on Neurology published in 2025, neurological conditions now affect more than 40% of the global population, representing over 3 billion people, and remain the leading cause of ill health and disability worldwide. Hence, several companies and research institutes are investing in clinical trials, including the application of digital technologies in neurology.
Global Digital Health In Neurology Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the global digital health in neurology market report based on component, end use, and region:Component Outlook (Revenue, USD Million, 2021 - 2033)
- Software
- Hardware
- Services
End Use Outlook (Revenue, USD Million, 2021 - 2033)
- Patients
- Providers
- Payers
- Others
Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
▪ Canada
- Europe
▪ Germany
▪ France
▪ Italy
▪ Spain
▪ Sweden
▪ Denmark
▪ Norway
- Asia Pacific
▪ India
▪ Japan
▪ Australia
▪ South Korea
▪ Singapore
- Latin America
▪ Mexico
▪ Argentina
- MEA
▪ Saudi Arabia
▪ UAE
▪ Kuwait
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Digital Health In Neurology Market Variables, Trends & Scope
Chapter 4. Digital Health In Neurology Market: Component Estimates & Trend Analysis
Chapter 5. Digital Health In Neurology Market: End Use Estimates & Trend Analysis
Chapter 6. Digital Health In Neurology Market: Regional Estimates & Trend Analysis, Component, End Use
Chapter 7. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
- Neofect Co., Ltd.
- Teladoc Health, Inc.
- Proteus Digital Health, Inc.
- Akili, Inc.
- AppliedVR, Inc.
- Aural Analytics, Inc.
- BehaVR, Inc.
- Big Health Inc.
- Omada Health, Inc.
- Blackrock Neurotech
- AdvancedMD, Inc.
